Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study

go back to reference Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, investigators B (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372(9641):817–821. https://doi.org/10.1016/S0140-6736(08)61171-X CrossRefPubMed Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, investigators B (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372(9641):817–821. https://​doi.​org/​10.​1016/​S0140-6736(08)61171-X CrossRefPubMed

go back to reference Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376(9744):886–894. https://doi.org/10.1016/S0140-6736(10)61259-7 CrossRefPubMed Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376(9744):886–894. https://​doi.​org/​10.​1016/​S0140-6736(10)61259-7 CrossRefPubMed

go back to reference Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113(6):1489–1494CrossRef Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113(6):1489–1494CrossRef

go back to reference Tardif JC, Ponikowski P, Kahan T, Investigators AS (2009) Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 30(5):540–548. https://doi.org/10.1093/eurheartj/ehn571 CrossRefPubMedPubMedCentral Tardif JC, Ponikowski P, Kahan T, Investigators AS (2009) Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 30(5):540–548. https://​doi.​org/​10.​1093/​eurheartj/​ehn571 CrossRefPubMedPubMedCentral

go back to reference Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875–885. https://doi.org/10.1016/S0140-6736(10)61198-1 CrossRefPubMed Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875–885. https://​doi.​org/​10.​1016/​S0140-6736(10)61198-1 CrossRefPubMed

go back to reference Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM (2006) High heart rate: a cardiovascular risk factor? Eur Heart J 27(20):2387–2393. https://doi.org/10.1093/eurheartj/ehl259 CrossRefPubMed Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM (2006) High heart rate: a cardiovascular risk factor? Eur Heart J 27(20):2387–2393. https://​doi.​org/​10.​1093/​eurheartj/​ehl259 CrossRefPubMed

go back to reference Inoue T, Oshiro S, Iseki K, Tozawa M, Touma T, Ikemiya Y, Takishita S (2001) High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J 65(11):969–973CrossRef Inoue T, Oshiro S, Iseki K, Tozawa M, Touma T, Ikemiya Y, Takishita S (2001) High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J 65(11):969–973CrossRef

go back to reference Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Bohm M (2014) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 103(2):149–159. https://doi.org/10.1007/s00392-013-0644-4 CrossRefPubMed Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Bohm M (2014) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 103(2):149–159. https://​doi.​org/​10.​1007/​s00392-013-0644-4 CrossRefPubMed

go back to reference McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Guidelines ESCCfP (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14 (8):803–869. https://doi.org/10.1093/eurjhf/hfs105 CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Guidelines ESCCfP (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14 (8):803–869. https://​doi.​org/​10.​1093/​eurjhf/​hfs105 CrossRefPubMed

go back to reference Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Ryden L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003. https://doi.org/10.1093/eurheartj/eht296 CrossRef Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Ryden L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003. https://​doi.​org/​10.​1093/​eurheartj/​eht296 CrossRef

go back to reference Fox K, Ford I, Ferrari R (2014) Ivabradine in stable coronary artery disease. N Engl J Med 371(25):2435. https://doi.org/10.1056/NEJMc1413158 CrossRefPubMed Fox K, Ford I, Ferrari R (2014) Ivabradine in stable coronary artery disease. N Engl J Med 371(25):2435. https://​doi.​org/​10.​1056/​NEJMc1413158 CrossRefPubMed

go back to reference Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, Pfeiffer N, Munzel T, Blankenberg S (2012) The Gutenberg Health Study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6–7):824–829. https://doi.org/10.1007/s00103-012-1502-7 CrossRefPubMed Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, Pfeiffer N, Munzel T, Blankenberg S (2012) The Gutenberg Health Study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6–7):824–829. https://​doi.​org/​10.​1007/​s00103-012-1502-7 CrossRefPubMed

go back to reference Schnabel RB, Wild PS, Schulz A, Zeller T, Sinning CR, Wilde S, Kunde J, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Munzel T, Gutenberg Health Study I (2012) Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study. Hypertension 60(2):288–295. https://doi.org/10.1161/HYPERTENSIONAHA.112.191874 CrossRefPubMed Schnabel RB, Wild PS, Schulz A, Zeller T, Sinning CR, Wilde S, Kunde J, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Munzel T, Gutenberg Health Study I (2012) Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study. Hypertension 60(2):288–295. https://​doi.​org/​10.​1161/​HYPERTENSIONAHA.​112.​191874 CrossRefPubMed

go back to reference Grossmann V, Schmitt VH, Zeller T, Panova-Noeva M, Schulz A, Laubert-Reh D, Juenger C, Schnabel RB, Abt TG, Laskowski R, Wiltink J, Schulz E, Blankenberg S, Lackner KJ, Munzel T, Wild PS (2015) Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 38(7):1356–1364. https://doi.org/10.2337/dc14-3008 CrossRefPubMed Grossmann V, Schmitt VH, Zeller T, Panova-Noeva M, Schulz A, Laubert-Reh D, Juenger C, Schnabel RB, Abt TG, Laskowski R, Wiltink J, Schulz E, Blankenberg S, Lackner KJ, Munzel T, Wild PS (2015) Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 38(7):1356–1364. https://​doi.​org/​10.​2337/​dc14-3008 CrossRefPubMed

go back to reference Arnold N, Gori T, Schnabel RB, Schulz A, Prochaska JH, Zeller T, Binder H, Pfeiffer N, Beutel M, Espinola-Klein C, Lackner KJ, Blankenberg S, Munzel T, Wild PS (2017) Relation between arterial stiffness and markers of inflammation and hemostasis—data from the population-based gutenberg health study. Sci Rep 7(1):6346. https://doi.org/10.1038/s41598-017-06175-2 CrossRefPubMedPubMedCentral Arnold N, Gori T, Schnabel RB, Schulz A, Prochaska JH, Zeller T, Binder H, Pfeiffer N, Beutel M, Espinola-Klein C, Lackner KJ, Blankenberg S, Munzel T, Wild PS (2017) Relation between arterial stiffness and markers of inflammation and hemostasis—data from the population-based gutenberg health study. Sci Rep 7(1):6346. https://​doi.​org/​10.​1038/​s41598-017-06175-2 CrossRefPubMedPubMedCentral

go back to reference Trenkwalder T, Rubsamen N, Schmitt VH, Arnold N, Kaess BM, Sinning CR, Zeller T, Beutel ME, Schmidtmann I, Nickels S, Pfeiffer N, Leuschner A, Munzel T, Lackner KJ, Hengstenberg C, Blankenberg S, Wild PS, Reinhard W, Schnabel R (2019) Left ventricular geometry and function in early repolarization: results from the population-based Gutenberg Health Study. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01445-7 CrossRefPubMedPubMedCentral Trenkwalder T, Rubsamen N, Schmitt VH, Arnold N, Kaess BM, Sinning CR, Zeller T, Beutel ME, Schmidtmann I, Nickels S, Pfeiffer N, Leuschner A, Munzel T, Lackner KJ, Hengstenberg C, Blankenberg S, Wild PS, Reinhard W, Schnabel R (2019) Left ventricular geometry and function in early repolarization: results from the population-based Gutenberg Health Study. Clin Res Cardiol. https://​doi.​org/​10.​1007/​s00392-019-01445-7 CrossRefPubMedPubMedCentral

go back to reference Schnabel RB, Schulz A, Wild PS, Sinning CR, Wilde S, Eleftheriadis M, Herkenhoff S, Zeller T, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Munzel T (2011) Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 4(4):371–380. https://doi.org/10.1161/CIRCIMAGING.110.961557 CrossRefPubMed Schnabel RB, Schulz A, Wild PS, Sinning CR, Wilde S, Eleftheriadis M, Herkenhoff S, Zeller T, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Munzel T (2011) Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 4(4):371–380. https://​doi.​org/​10.​1161/​CIRCIMAGING.​110.​961557 CrossRefPubMed

go back to reference World Health Organization. Collaborating Centre for Drug Statistics Methodology. https://www.whocc.no/atc/structure_and_principles/. Accessed 22 Jan 2019 World Health Organization. Collaborating Centre for Drug Statistics Methodology. https://​www.​whocc.​no/​atc/​structure_​and_​principles/​. Accessed 22 Jan 2019

go back to reference Palatini P, Julius S (1997) Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 11(Suppl 1):S19–S27PubMed Palatini P, Julius S (1997) Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 11(Suppl 1):S19–S27PubMed

go back to reference Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S (1997) Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 30(5):1267–1273CrossRef Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S (1997) Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 30(5):1267–1273CrossRef

go back to reference Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, Marz W, Wittchen HU, Zeiher AM, Group DE-S (2012) Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information? Eur J Prev Cardiol 19(2):275–284. https://doi.org/10.1177/1741826710394304 CrossRefPubMed Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, Marz W, Wittchen HU, Zeiher AM, Group DE-S (2012) Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information? Eur J Prev Cardiol 19(2):275–284. https://​doi.​org/​10.​1177/​1741826710394304​ CrossRefPubMed

go back to reference Berenson GS, Voors AW, Webber LS, Dalferes ER Jr, Harsha DW (1979) Racial differences of parameters associated with blood pressure levels in children–the Bogalusa heart study. Metabolism 28(12):1218–1228CrossRef Berenson GS, Voors AW, Webber LS, Dalferes ER Jr, Harsha DW (1979) Racial differences of parameters associated with blood pressure levels in children–the Bogalusa heart study. Metabolism 28(12):1218–1228CrossRef

go back to reference Zhang J, Kesteloot H (1999) Anthropometric, lifestyle and metabolic determinants of resting heart rate. A population study. Eur Heart J 20(2):103–110CrossRef Zhang J, Kesteloot H (1999) Anthropometric, lifestyle and metabolic determinants of resting heart rate. A population study. Eur Heart J 20(2):103–110CrossRef

go back to reference Park BJ, Lee HR, Shim JY, Lee JH, Jung DH, Lee YJ (2010) Association between resting heart rate and arterial stiffness in Korean adults. Arch Cardiovasc Dis 103(4):246–252. https://doi.org/10.1016/j.acvd.2010.03.004 CrossRefPubMed Park BJ, Lee HR, Shim JY, Lee JH, Jung DH, Lee YJ (2010) Association between resting heart rate and arterial stiffness in Korean adults. Arch Cardiovasc Dis 103(4):246–252. https://​doi.​org/​10.​1016/​j.​acvd.​2010.​03.​004 CrossRefPubMed

go back to reference Baier D, Teren A, Wirkner K, Loeffler M, Scholz M (2018) Parameters of pulse wave velocity: determinants and reference values assessed in the population-based study LIFE-Adult. Clin Res Cardiol 107(11):1050–1061. https://doi.org/10.1007/s00392-018-1278-3 CrossRefPubMedPubMedCentral Baier D, Teren A, Wirkner K, Loeffler M, Scholz M (2018) Parameters of pulse wave velocity: determinants and reference values assessed in the population-based study LIFE-Adult. Clin Res Cardiol 107(11):1050–1061. https://​doi.​org/​10.​1007/​s00392-018-1278-3 CrossRefPubMedPubMedCentral

go back to reference Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M, Heart Rate Working G (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50(9):823–830. https://doi.org/10.1016/j.jacc.2007.04.079 CrossRefPubMed Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M, Heart Rate Working G (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50(9):823–830. https://​doi.​org/​10.​1016/​j.​jacc.​2007.​04.​079 CrossRefPubMed

go back to reference Custodis F, Roggenbuck U, Lehmann N, Moebus S, Laufs U, Mahabadi AA, Heusch G, Mann K, Jockel KH, Erbel R, Bohm M, Mohlenkamp S (2016) Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population. Clin Res Cardiol 105(7):601–612. https://doi.org/10.1007/s00392-015-0956-7 CrossRefPubMed Custodis F, Roggenbuck U, Lehmann N, Moebus S, Laufs U, Mahabadi AA, Heusch G, Mann K, Jockel KH, Erbel R, Bohm M, Mohlenkamp S (2016) Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population. Clin Res Cardiol 105(7):601–612. https://​doi.​org/​10.​1007/​s00392-015-0956-7 CrossRefPubMed

go back to reference Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werko L (1986) The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 7(4):279–288CrossRef Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werko L (1986) The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 7(4):279–288CrossRef

go back to reference Gillum RF, Makuc DM, Feldman JJ (1991) Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 121(1 Pt 1):172–177CrossRef Gillum RF, Makuc DM, Feldman JJ (1991) Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 121(1 Pt 1):172–177CrossRef

go back to reference Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2015) Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131(4):e29–e322. https://doi.org/10.1161/CIR.0000000000000152 CrossRefPubMed Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2015) Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131(4):e29–e322. https://​doi.​org/​10.​1161/​CIR.​0000000000000152​ CrossRefPubMed

go back to reference Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, Investigators I (2005) Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 26(23):2529–2536. https://doi.org/10.1093/eurheartj/ehi586 CrossRefPubMed Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, Investigators I (2005) Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 26(23):2529–2536. https://​doi.​org/​10.​1093/​eurheartj/​ehi586 CrossRefPubMed

go back to reference Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO (2018) Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart. Clin Res Cardiol 107(2):138–147. https://doi.org/10.1007/s00392-017-1165-3 CrossRefPubMed Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO (2018) Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart. Clin Res Cardiol 107(2):138–147. https://​doi.​org/​10.​1007/​s00392-017-1165-3 CrossRefPubMed